Utthara Nayar, PhDJohns Hopkins UniversityBaltimore, MD Estrogen receptor mutations as a novel biomarker for response to endocrine therapy in ovarian cancer Dr. Nayar is pursuing a fast track to the clinical testing of a new treatment for low-grade serous ovarian cancers (LGSOCs). Some LGSOCs develop mutations in the estrogen receptor (ER) molecule and stop responding […]
Read MoreStarting April 1, 2025, the Rivkin Center’s ovarian cancer research funding, global symposium and fundraising activities will continue under the leadership of Ovarian Cancer Research Alliance (OCRA).